MedPath

Sulfadoxine-Pyrimethamine

Generic Name
Sulfadoxine-Pyrimethamine
Brand Names
-
Drug Type
-
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Indication

用于防治耐氯喹的恶性疟原虫所致的疟疾。

Associated Conditions
-
Associated Therapies
-

Combination Antimalarials in Uncomplicated Malaria

Not Applicable
Completed
Conditions
Malaria
First Posted Date
2005-09-20
Last Posted Date
2018-10-19
Lead Sponsor
University of Cape Town
Target Recruit Count
700
Registration Number
NCT00203801
Locations
🇿🇦

Naas Clinic, Naas, Mpumalanga, South Africa

🇿🇦

Lulekani Clinic, Lulekani, Limpopo, South Africa

🇲🇿

Bela Vista Clinic, Bela Vista, Matutuine, Mozambique

and more 4 locations

Reducing the Effects of Malaria in Children by Administering Repeated Preventive Doses

Phase 4
Completed
Conditions
Malaria
First Posted Date
2005-09-14
Last Posted Date
2013-01-24
Lead Sponsor
Albert Schweitzer Hospital
Target Recruit Count
1189
Registration Number
NCT00167843
Locations
🇬🇦

Medical Research Unit of the Albert Schweitzer Hospital, Lambaréné, Moyen Ogooué, Gabon

Assessing the Efficacy of Four Drug Combinations as the Next First-line Therapy for Uncomplicated Malaria in Malawi

Phase 4
Completed
Conditions
Malaria, Falciparum
First Posted Date
2005-09-14
Last Posted Date
2012-09-27
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
365
Registration Number
NCT00164710
Locations
🇲🇼

Kawale Health Center, Lilongwe, Lilongwe District, Malawi

🇲🇼

Machinga District Hospital, Liwonde, Machinga District, Malawi

🇲🇼

Matiki Health Center, Dwangwa, Nkhotakota District, Malawi

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

Phase 4
Completed
Conditions
Malaria
HIV
AIDS
First Posted Date
2005-09-05
Last Posted Date
2005-09-05
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
540
Registration Number
NCT00144352
Locations
🇰🇪

CDC KEMRI Research Institute, Kisumu, Kenya

Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria

Phase 4
Completed
Conditions
Malaria (Uncomplicated)
First Posted Date
2005-09-01
Last Posted Date
2012-09-11
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
390
Registration Number
NCT00140361
Locations
🇹🇿

Ngere Ngere Health Center, Ngere Ngere, Morogoro Rural, Tanzania

🇹🇿

Ikwiriri Health Center, Ikwiriri, Rufiji, Tanzania

🇹🇿

Lupiro Health Center, Lupiro, Ulanga, Tanzania

Prevention of Severe Anaemia in Gambian Children

Phase 3
Completed
Conditions
Anemia
First Posted Date
2005-08-19
Last Posted Date
2017-01-12
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
1200
Registration Number
NCT00131716
Locations
🇬🇲

Medical Research Council Laboratories,, Banjul, Gambia

Antimalarial Drug Resistance in Mali

Not Applicable
Completed
Conditions
Malaria
First Posted Date
2005-08-09
Last Posted Date
2006-08-16
Lead Sponsor
Centers for Disease Control and Prevention
Target Recruit Count
1011
Registration Number
NCT00127998
Locations
🇲🇱

Koro Health Center, Koro, Mali

🇲🇱

Faladje Missionary Dispensary, Faladje, Mali

🇲🇱

Pongono Community Health Center, Pongono, Mali

Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae

Phase 3
Completed
Conditions
Malaria
First Posted Date
2005-07-19
Last Posted Date
2017-01-12
Lead Sponsor
London School of Hygiene and Tropical Medicine
Target Recruit Count
3000
Registration Number
NCT00120809
Locations
🇬🇲

Medical Research Council Laboratories, Banjul, Gambia

© Copyright 2025. All Rights Reserved by MedPath